Charter, bylaw, and control-related changes under 8-K Items 5.03/5.05/5.06.
PRESIDIO PRODUCTION Co: Adopted amended and restated bylaws in connection with business combination (effective 2026-03-04).
“the Company filed the Certificate of Incorporation with the Secretary of State of the State of Delaware and amended and restated the Company’s bylaws”
PRESIDIO PRODUCTION Co: Filed Certificate of Incorporation in connection with business combination (effective 2026-03-04).
“On the Closing Date, in connection with the consummation of the Business Combination, the Company filed the Certificate of Incorporation with the Secretary of State of the State of Delaware and amended and restated the Company’s bylaws”
Forward Industries, Inc.: Reincorporation from New York to Texas, adopting Texas Charter and Texas Bylaws effective March 5, 2026 (effective 2026-03-05).
“At the Effective Time: · the Company’s state of incorporation changed from the State of New York to the State of Texas; and · the internal affairs of the Company ceased to be governed by the laws of the State of New York and the Company’s existing restated certificate of incorporation and amended and restated bylaws, and instead became governed by the laws of the State of Texas and the certificate of formation filed with the Secretary of State of the State of Texas (the “Texas Charter”) and the bylaws approved by the Company’s board of directors (the “Texas Bylaws”).”
Prospect Floating Rate & Alternative Income Fund, Inc.: Adopted Fifth Amended and Restated Bylaws to conform to NASAA Omnibus Guidelines, changing director election voting standard and requiring stockholder majority concurrence for adverse bylaw amendments (effective 2026-03-04).
“On March 4, 2026, the Company adopted the Fifth Amended and Restated Bylaws for the purpose of amending the Company’s Fourth Amended and Restated Bylaws to conform to provisions of the NASAA Omnibus Guidelines.”
Prospect Floating Rate & Alternative Income Fund, Inc.: Amended Fourth Articles to conform to NASAA Omnibus Guidelines, increasing quorum to 50%, dividing common stock into four classes, and changing stockholder meeting and director removal provisions (effective 2026-03-06).
“On March 6, 2026, the Company filed its Fifth Articles of Amendment and Restatement with the State Department of Assessments and Taxation of Maryland and the amendment became effective immediately upon filing.”
James River Group Holdings, Inc.: Amended Code of Conduct to update provisions on confidential information and clarify compliance with Employee Handbook (effective 2026-03-02).
“On March 2, 2026, the Company approved certain amendments to its Code of Conduct (as amended, the “Code”).”
ARTELO BIOSCIENCES, INC.: Effected a one-for-three reverse stock split of common stock and reduced authorized shares accordingly (effective 2026-03-10).
“On March 5, 2026, Artelo Biosciences, Inc., a Nevada corporation (the “Company”), filed with the Secretary of State of the State of Nevada a Certificate of Change (the “Certificate of Change”), pursuant to Nevada Revised Statutes 78.209, to effect a one-for-three (1-for-3) reverse stock split (the “Reverse Split”) of the Company’s issued and outstanding common stock, par value $0.001 per share (the “Common Stock”).”
LQR House Inc.: The Company adopted new Delaware Bylaws upon reincorporation from Nevada to Delaware (effective 2026-03-02).
“the affairs of the Company ceased to be governed by the laws of the State of Nevada and the Company’s existing Amended and Restated Aritcles of Incorporation and Amended and Restated Bylaws, and instead became governed by the laws of the State of Delaware and the Delaware Charter and the Bylaws approved by the Company’s board of directors (the “ Delaware Bylaws ”).”
LQR House Inc.: The Company reincorporated from Nevada to Delaware, adopting a new Delaware Certificate of Incorporation (effective 2026-03-02).
“the Company filed (i) a Certificate of Conversion with the Secretary of State of the State of Delaware (the “ Certificate of Conversion ”), (ii) an Articles of Conversion with the Secretary of State of the State of Nevada (the “ Articles of Conversion ”) and (iii) a Certificate of Incorporation with the Secretary of State of the State of Delaware (the “ Delaware Charter ”), pursuant to which the Reincorporation became effective immediatley upon filing”
Unum Group: Amended Bylaws to replace 'Chairman' with 'Chair', clarify remote shareholder participation, vote denominator, board authority over proposals, updated definitions, remove obsolete provisions, and update indemnification list (effective 2026-03-04).
“On March 4, 2026, the Board of Directors of Unum Group (the “Company”) adopted amendments to the Company's Amended and Restated Bylaws (the “Bylaws”).”
MIDDLEBY Corp: Amended and restated bylaws to increase maximum board size from 11 to 13 directors and update officer titles and executive officer positions (effective 2026-03-05).
“On March 5, 2026, the Board, in connection with the Board’s periodic review of corporate governance matters, adopted and approved an amendment and restatement of the Company’s Fourth Amended and Restated Bylaws (as so amended and restated, the “Fifth Amended and Restated By-Laws”), effective immediately, in order to (1) increase the upper limit of the Board’s size from eleven (11) to thirteen (13) directors and (2) update officer titles and executive officer positions.”
Bank of New York Mellon Corp: Filed Certificate of Designations to establish terms of Series M Noncumulative Perpetual Preferred Stock (effective 2026-03-04).
“On March 4, 2026, the Registrant filed a Certificate of Designations (the “Certificate of Designations”) with the Secretary of State of the State of Delaware to establish the preferences, limitations and relative rights of the Series M Preferred Stock.”
Sabre Corp: Filed a Certificate of Designations of Series B Preferred Stock in connection with adoption of a Rights Agreement (effective 2026-03-01).
“In connection with the adoption of the Rights Agreement, on March 1, 2026, the Company filed a Certificate of Designations of Series B Preferred Stock with the Secretary of State of the State of Delaware setting forth the rights, powers and preferences of the Series B Preferred Stock issuable upon exercise of the Rights (the “Preferred Shares”).”
Decoy Therapeutics Inc.: Amended Certificate of Incorporation to effect a 1-for-12 reverse stock split of common stock (effective 2026-03-06).
“On March 5, 2026, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment to its Certificate of Incorporation (the “Certificate of Amendment”) to effect the Reverse Stock Split.”
Aditxt, Inc.: Amended certificate of incorporation to effect a one-for-eight reverse stock split (effective 2026-03-06).
“On March 5, 2026, the Company filed with the Secretary of State of the State of Delaware a certificate of amendment to its certificate of incorporation (the “ Certificate of Amendment ”) to effect the Reverse Stock Split. The Reverse Stock Split will become effective as of 4:01 p.m. Eastern Time on March 6, 2026, and the Company’s common stock will begin trading on a split-adjusted basis when the Nasdaq Stock Market opens on March 9, 2026.”
REVIVA PHARMACEUTICALS HOLDINGS, INC.: Filing of Certificate of Amendment to effect a one-for-twenty reverse stock split (effective 2026-03-09).
“filed a Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware”
Sky Quarry Inc.: Filed Certificate of Amendment to effect a 1-for-8 reverse stock split (effective 2026-03-15).
“On March 5, 2026, the Sky Quarry Inc. (the “Company”) filed its Certificate of Amendment to the Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of Delaware to (i) effect on the corporate level a one-for-eight (1-for-8) reverse stock split (the “Reverse Stock Split”) of the Company’s shares of Common Stock, par value $0.0001 (the “Common Stock”).”
La Rosa Holdings Corp.: Filed Certificate of Designation creating Series C Convertible Preferred Stock (effective 2026-03-04).
“On March 3, 2026, in connection with the SPA, the Board of Directors of the Company approved, and on March 4, 2026 the Company filed, the Certificate of Designation with the Secretary of State of the State of Nevada, designating 100 shares of preferred stock of the Company as Series C Preferred Stock.”
C2 Blockchain, Inc.: Increased authorized capital stock to 1,520,000,000 shares and designated 5,000,000 shares as Series A Preferred Stock with 100 votes per share and convertibility (effective 2026-03-04).
“On March 4, 2026, the Company filed Amended and Restated Articles of Incorporation with the Secretary of State of the State of Nevada (the “Amended and Restated Articles”). The Amended and Restated Articles, among other things, increase the Company’s authorized capital stock to an aggregate of 1,520,000,000 shares, consisting of 1,500,000,000 shares of common stock, par value $0.001 per share, and 20,000,000 shares of preferred stock, par value $0.001 per share.”
Core Laboratories Inc. /DE/: Lowered voting threshold for shareholder actions from 66-2/3% supermajority to simple majority (effective 2026-02-27).
“the only change being to lower the voting threshold set forth in Section 2.11 for approval of certain shareholder actions, including the approval of merger and change in control transactions, from a 66-2/3% supermajority vote to a 50% plus one simple majority vote”
Classover Holdings, Inc.: Reverse stock split at a ratio of 1-for-50 and reduction in authorized common stock from 50,000,000 shares of Class A to 1,000,000 and from 2,000,000,000 shares of Class B to 40,000,000, effective March 9, 2026 (effective 2026-03-09).
“the Company filed a certificate of amendment to its certificate of incorporation, as amended, pursuant to which the Reverse Split and the Reduction in Authorized Common Stock will become effective on March 9, 2026, at 12:01 a.m. Eastern Time”
PIMCO Asset-Based Lending Co LLC: Amended and restated LLC agreement to add Anchor I-B and Anchor III share classes, remove Class D shares, modify duties/standards for Operating Manager and Board, and expand indemnification provisions (effective 2026-03-04).
“On March 4, 2026, the Company executed its Second Amended and Restated Limited Liability Company Agreement (the “Second A&R LLCA”) (as further amended or amended and restated from time to time), which amended and restated the Company’s Amended and Restated Limited Liability Company Agreement (“A&R LLCA”), dated as of June 12, 2025.”
GalaxyEdge Acquisition Corp: Adopted Second Amended and Restated Memorandum and Articles of Association, replacing the prior Amended and Restated Memorandum and Articles of Association (effective 2026-03-03).
“On March 3, 2026, the Company adopted its Second Amended and Restated Memorandum and Articles of Association, which replaced the Company’s previously effective Amended and Restated Memorandum and Articles of Association.”
Kensington Capital Acquisition Corp. VI: Amended and Restated Memorandum and Articles of Association filed (effective 2026-03-04).
“On March 4, 2026, the Company filed its Amended and Restated Memorandum and Articles of Association.”
FAIR ISAAC CORP: Stockholders approved amendments to the Restated Certificate of Incorporation to allow exculpation of officers as permitted by Delaware law and to eliminate supermajority voting requirement to amend or repeal Article 6 (effective 2026-03-04).
“the stockholders of the Company approved (i) an amendment to the Company's Restated Certificate of Incorporation to allow for exculpation of officers as permitted by Delaware law, and (ii) an amendment to the Company's Restated Certificate of Incorporation to eliminate the supermajority voting requirement that requires at least 66-2/3% of the voting power of the Company's outstanding shares to amend or repeal Article 6 thereof (collectively, the "Charter Amendments").”
Ventyx Biosciences, Inc.: Amended and restated certificate of incorporation effective at the Effective Time of the Merger.
“the certificate of incorporation and bylaws of the Company were amended and restated in accordance with the terms of the Merger Agreement”
Ventyx Biosciences, Inc.: Amended and restated bylaws effective at the Effective Time of the Merger.
“the certificate of incorporation and bylaws of the Company were amended and restated in accordance with the terms of the Merger Agreement”
Tevogen Bio Holdings Inc.: Effected a 1-for-50 reverse stock split by filing a Certificate of Amendment to the Certificate of Incorporation, effective March 6, 2026 (effective 2026-03-06).
“On March 3, 2026, Tevogen Bio Holdings Inc. (the “Company”) filed a Certificate of Amendment to its Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-50 reverse stock split of the issued and outstanding common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Reverse Stock Split”), to be effective as of March 6, 2026 (the “Effective Date”).”
Liminatus Pharma, Inc.: Reduced stockholder meeting quorum requirement from majority to one-third of voting power (effective 2026-02-27).
“On February 27, 2026, the Board of Directors (the “Board”) of Liminatus Pharma, Inc. (the “Company”) approved an amendment to the Company’s bylaws (the “Bylaws”) to reduce the quorum requirement for meetings of the stockholders from a majority to one-third (1/3) of the voting power of the capital stock of the Company issued and outstanding and entitled to vote (the “Bylaw Amendment”).”
TRANSACT TECHNOLOGIES INC: Amended and restated By-Laws to update virtual meeting provisions, stockholder proposal procedures, director compensation, and other administrative items, effective February 25, 2026 (effective 2026-02-25).
“On February 25, 2026, the Board of Directors (the “Board”) of TransAct Technologies Incorporated (the “Company”) amended and restated the Amended and Restated By-Laws of the Company (as amended and restated, the “Amended By-Laws”), effective as of such date.”
Global Arena Holding, Inc.: Filed an Amended and Restated Certificate of Designations for Series A convertible preferred stock, setting number of authorized shares, stated value, conversion terms, voting rights, and other provisions (effective 2026-02-27).
“On February 27, 2026, the Company filed an Amended and Restated Certificate of Designations of Preferences and Rights (the “A&R Certificate of Designations”) of the Series A convertible preferred stock (the “Series A Preferred Stock”) with the Secretary of State of the State of Delaware.”
PEDEVCO CORP: Amended and restated charter to increase authorized common shares from 200M to 300M, remove reverse stock split references, update director provisions, add corporate opportunities waiver for certain investor groups, revise supermajority and majority voting provisions, remove Series A Preferred Stock (effective 2026-02-27).
“On February 27, 2026, the Company filed the A&R Charter with the Secretary of State of Texas, which amendment was effective the same date.”
Quanex Building Products CORP: Board approved several amendments to the Fourth Amended and Restated Bylaws, resulting in the Fifth Amended and Restated Bylaws, including changes related to remote stockholder meetings, universal proxy rules, procedural mechanics for stockholder nominations, director qualification information, remo (effective 2026-02-26).
“On February 26, 2026, the Board of Directors (the “Board”) of Quanex Building Products Corporation (the “Company”) approved several amendments to the Company’s Fourth Amended and Restated Bylaws (the “Bylaws”).”
Meridian Holdings Inc./NV: Changed company name to 'Meridian Holdings Inc.' (effective 2026-03-03).
“a Certificate of Amendment to the Company’s Articles of Incorporation, as amended, to affect the Name Change.”
Meridian Holdings Inc./NV: Approved a 1-for-12 reverse stock split of common stock (effective 2026-03-03).
“On February 26, 2026, the Company filed both (a) a Certificate of Change with the Secretary of State of the State of Nevada (the “ Certificate of Change ”) to effectuate the Reverse Split of its Common Stock at a ratio of 1-for-12”
Jaguar Health, Inc.: Filed Certificate of Designation for Series O Convertible Preferred Stock (effective 2026-03-02).
“on March 2, 2026 the Company filed a Certificate of Designation of Preferences, Rights and Limitations of Series O Convertible Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware, to designate 1,557,000 shares of the Company’s preferred stock, par value $0.0001 per share, as Series O Convertible Preferred Stock”
RAPT Therapeutics, Inc.: Amended and restated the company's bylaws at the effective time of the merger.
“Pursuant to the terms of the Merger Agreement, at the Effective Time, the Company’s certificate of incorporation and bylaws were each amended and restated in their entirety”
RAPT Therapeutics, Inc.: Amended and restated the company's certificate of incorporation at the effective time of the merger.
“Pursuant to the terms of the Merger Agreement, at the Effective Time, the Company’s certificate of incorporation and bylaws were each amended and restated in their entirety”
Aphoenity International Holdings Inc.: Changed IRS EIN number (effective 2025-11-18).
“Change of the Company’s EIN Number: Effective as from November 18, 2025, the Company’s IRS EIN number has been changed into 98-1872097”
Aphoenity International Holdings Inc.: Completed 1,000-for-1 reverse stock split (effective 2025-11-18).
“1,000-for-1 Reverse Stock Split: Effective as from November 18, 2025, the Company has completed a reverse stock split of its common stocks”
Aphoenity International Holdings Inc.: Changed company name from Luduson G Inc. to Aphoenity International Holdings Inc (effective 2025-10-01).
“Change of the Company’s Name: Effective as from October 1, 2025, the Company’s name has been changed from “Luduson G Inc.” into “Aphoenity International Holdings Inc.””
Aphoenity International Holdings Inc.: Changed domicile from Delaware to Wyoming (effective 2025-07-21).
“Change of the Company’s Domicile from Delaware to Wyoming: As of July 21, 2025, the Registrant has completed the change of its domicile from the State of Delaware to the State of Wyoming”
Transcode Therapeutics, Inc.: Filed Certificate of Designation for Series C Non-Voting Convertible Preferred Stock, establishing its preferences, rights, and limitations (effective 2026-03-02).
“On March 2, 2026, the Company filed a Certificate of Designation of Preferences, Rights and Limitations (the “Certificate of Designation”) of the Series C Non-Voting Convertible Preferred Stock, par value $0.0001 per share, (the “Series C Preferred Stock”) with the Secretary of State of the State of Delaware”
MOBIX LABS, INC: Reduced stockholder meeting quorum requirement from majority to one-third of voting power (effective 2026-02-27).
“The amendment of the Bylaws reduces the quorum requirement for all meetings of stockholders (unless otherwise provided by statute, the Company’s amended and restated certificate of incorporation or regulations of any stock exchange applicable to the Company) from the presence, in person or by proxy, of a majority in voting power of the then outstanding shares of stock entitled to vote to the presence, in person or by proxy, of one-third of the voting power of the outstanding shares of stock entitled to vote.”
Piermont Valley Acquisition Corp: Amended memorandum and articles of association to extend business combination deadline from March 3, 2026 to March 3, 2027 and allow board to elect earlier wind-up (effective 2026-03-02).
“proposal to amend, by special resolution, the Company’s amended and restated memorandum of association and articles of association, as amended to extend the date by which the Company would be required to consummate a business combination from March 3, 2026 to March 3, 2027 and (b) to permit the board of directors of the Company, in its sole discretion, to elect to wind up the Company’s operations on an earlier date than March 3, 2027”
Valuence Merger Corp. I: Amended Articles to extend business combination deadline from March 3, 2026 to May 3, 2026, with option for further monthly extensions by board resolution (effective 2026-02-27).
“At the Meeting, the Company’s shareholders approved a proposal (the “Extension Amendment Proposal”) to amend the Company’s Amended and Restated Memorandum and Articles of Association (the “Articles”) to extend the date by which the Company must consummate a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination from March 3, 2026 for an initial two month period to May 3, 2026 and to permit the Company, without another shareholder vote, by resolution of the Company’s board of directors (“Board”), to elect to further extend the Deadline Date up to ten (10) additional times for an additional one (1) month each time”
APEX Tech Acquisition Inc.: Adopted Second Amended and Restated Memorandum and Articles of Association effective February 25, 2026 (effective 2026-02-25).
“On February 25, 2026, in connection with the IPO, the Company adopted its Second Amended and Restated Memorandum and Articles of Association (the “Amended Charter”), effective the same day.”
EASTERN CO: Amended bylaws to reduce supermajority for shareholder amendments to simple majority, eliminate executive committee requirement, lower special meeting ownership threshold to 25% with procedural safeguards, revise shareholder proposal and director nomination procedures, clarify Chairman role, and mak (effective 2026-02-25).
“On February 25, 2026, the Board amended and restated the Amended and Restated Bylaws of the Company (as amended and restated, the “Amended Bylaws”), effective as of such date.”
INTERNATIONAL BUSINESS MACHINES CORP: Increased number of directors from thirteen to fourteen following election of Ramon Laguarta (effective 2026-03-01).
“Article III, Section 2 of IBM's By-laws was amended to increase the number of directors to fourteen, effective March 1, 2026.”
GYRE THERAPEUTICS, INC.: Gyre Therapeutics expects to file a Certificate of Designation of Preferences, Rights and Limitations of the Company Preferred Stock in connection with a merger, creating a new class of preferred stock with specific dividend, voting, conversion, and anti-takeover provisions (effective 2026-03-02).
“The Company expects to file with the Secretary of State of the State of Delaware a Certificate of Designation of Preferences, Rights and Limitations of the Company Preferred Stock (the "Certificate of Designation") in connection with the Merger referenced in Item 1.01 above.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.